Hélène Negre

745 total citations
7 papers, 125 citations indexed

About

Hélène Negre is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hélène Negre has authored 7 papers receiving a total of 125 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hélène Negre's work include CAR-T cell therapy research (4 papers), Corneal Surgery and Treatments (2 papers) and Ocular Surface and Contact Lens (2 papers). Hélène Negre is often cited by papers focused on CAR-T cell therapy research (4 papers), Corneal Surgery and Treatments (2 papers) and Ocular Surface and Contact Lens (2 papers). Hélène Negre collaborates with scholars based in United States, France and Netherlands. Hélène Negre's co-authors include Philipp B. Staber, Jürgen Kuball, Dirk H. Busch, David Henderson, Pere Barba, Matteo Doglio, Michael Hudecek, Andreas Kremer, Ulrich Jäger and Lulu Chu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Science Advances.

In The Last Decade

Hélène Negre

7 papers receiving 122 citations

Peers

Hélène Negre

ONCOL

IMMUN

MB

RNMI

BE

Jinlong Xu China

Sophia Bylsma United States

Bruce L. Levine United States

Nicole Verdun United States

Qiu-Chuan Zhuang China

Yue Tan China

Anna M. Sureda Spain

Anetta Marcinek Germany

John C. Molina United States

Alexis Cuffel France

Jinlong Xu China

Hélène Negre

139 ×1.5

ONCOL

42 ×1.3

IMMUN

37 ×1.2

MB

6 ×0.2

RNMI

41 ×1.6

BE

Citations per year, relative to Hélène Negre Hélène Negre (= 1×) peers Jinlong Xu

Countries citing papers authored by Hélène Negre

Since Specialization

Citations

This map shows the geographic impact of Hélène Negre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Negre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Negre more than expected).

Fields of papers citing papers by Hélène Negre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène Negre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Negre. The network helps show where Hélène Negre may publish in the future.

Co-authorship network of co-authors of Hélène Negre

This figure shows the co-authorship network connecting the top 25 collaborators of Hélène Negre. A scholar is included among the top collaborators of Hélène Negre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélène Negre. Hélène Negre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Jurkunas, Ula V., Aaron R. Kaufman, Jia Yin, et al.. (2025). Cultivated autologous limbal epithelial cell (CALEC) transplantation for limbal stem cell deficiency: a phase I/II clinical trial of the first xenobiotic-free, serum-free, antibiotic-free manufacturing protocol developed in the US. Nature Communications. 16(1). 1607–1607. 6 indexed citations

2.

Jurkunas, Ula V., Jia Yin, Sanming Li, et al.. (2023). Cultivated autologous limbal epithelial cell (CALEC) transplantation: Development of manufacturing process and clinical evaluation of feasibility and safety. Science Advances. 9(33). eadg6470–eadg6470. 20 indexed citations

3.

Chu, Lulu, Pere Barba, Matteo Doglio, et al.. (2023). Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle. Frontiers in Immunology. 14. 1303935–1303935. 75 indexed citations

4.

Luu, Maik, Michael Hudecek, Miriam Meyer, et al.. (2023). Accelerating development of engineered T cell therapies in the EU: current regulatory framework for studying multiple product versions and T2EVOLVE recommendations. Frontiers in Immunology. 14. 1280826–1280826. 4 indexed citations

5.

Daley, Heather, Hélène Negre, Sarah Nikiforow, et al.. (2018). Developing a robust competency program for the GMP novel cell therapy laboratory in the cell manipulation core facility laboratory at Dana-Farber Cancer Institute, Boston. Cytotherapy. 20(5). S79–S79. 1 indexed citations

6.

Negre, Hélène, Amy Cunningham, Holly Anderson, et al.. (2018). Personnel environmental monitoring during manufacture of manipulated cell therapy products. Cytotherapy. 20(5). S68–S68. 4 indexed citations

7.

Nikiforow, Sarah, Joana Murad, Heather Daley, et al.. (2016). A first-in-human phase I trial of NKG2D chimeric antigen receptor-T cells in AML/MDS and multiple myeloma.. Journal of Clinical Oncology. 34(15_suppl). TPS3102–TPS3102. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact